CONSUMATORI
Condizioni di venditaContattiCercaSitemap
HOME
PRODOTTI
QUALITA' CERTIFICATA
TESTIMONIANZE
OMEGA-3
RICERCA E SALUTE
Il FARMACISTA CONSIGLIA
LIBRI
OMEGOR IN FARMACIA
RISORSE
Bibliografia Scientifica
Domande e Risposte
Glossario
NEWSLETTER
U.G.A. NUTRACEUTICALS
E-SHOP OMEGOR
 
RISORSE / Bibliografia Scientifica
Torna al menu
pagina 
1 2 3

Salute del bambino
Agostoni, C., S. Trojan, et al. (1995)
"Neurodevelopmental quotient of healthy term infants at 4 months and feeding practice: the role of long-chain polyunsaturated fatty acids." Pediatric Research 38 (2): 262-6.
vai
AJCardio-DHA improves lipid measures in hyperlipidemic children (2005)
Engler MM, Engler MB. "Effect of docosahexaenoic acid on lipoprotein subclasses in hyperlipidemic children" (the EARLY study. American Journal of Cardiology, 2005;95(7):869-871 [ABSTRACT IN INGLESE E TRADOTTO IN ITALIANO]
vai
Burgess, J.R. and Stevens, L.J. (2003)
"Essential fatty acids in relation to attention deficit hyperactivity disorder." Phospholipid Spectrum Disorders in Psychatry and Neurology, Peet, M., Glen, I., Horrobin, D.F. (eds.), Editor. Marius Press: Carnforth. p. 511-519
vai
Carlson, S. E. and S. H. Werkman (1996)
"A randomized trial of visual attention of preterm infants fed docosahexaenoic acid until two months." Lipids 31(1): 85-90
vai
Chen, J.R., Hsu, S.F., Hsu, C.D., Hwang, L.H., Yang, S.C. (2004)
"Dietary patterns and blood fatty acid composition in children with attention-deficit hyperactivity disorder in Taiwan." J Nutr Biochem. 15(8):467-72. Department of Nutrition and Health Sciences, Taipei Medical University, Taiwan.
vai
Hirayama S, Hamazaki T, Terasawa K (2004)
"Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder - a placebo-controlled double-blind study." Eur J Clin Nutr. 2004 Mar;58(3):467-73.
vai

Torna al menu
pagina 
1 2 3
 Credits ©2006 - U.G.A. Nutraceuticals S.r.l. - P.IVA 02801680543